Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%
Granules India has reported total income of Rs. 1,384.29 crore during the period ended December 31, 2025
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
Enabling a new era in minimally invasive obesity treatment across Europe
The event will be attended by 35,000+ industry professionals
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
_256_384.jpg)
Marksans Pharma gets USFDA nod for acid reflux drug
Subscribe To Our Newsletter & Stay Updated
